Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SENS-401 in cochlear implantation candidates
NCT05258773Phase 2Completed
- Sponsor
- Sensorion
- Start
- Aug 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of arazasetron besylate in hearing loss, sponsored by Sensorion. Started Aug 2022; status: completed.
02
Drugs
arazasetron besylate
03
Conditions
hearing loss
Beyond the preview
Go deeper on NCT05258773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05258773.